Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    Greece Hungary Romania
  • Study of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Croatia Czechia France Germany Greece +5
  • Study on the Safety and Effectiveness of Furmonertinib vs. Platinum-Based Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France Italy The Netherlands Spain
  • Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Not recruiting

    2 1 1 1
    France Greece Hungary Italy Poland Spain
  • Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium Estonia France Germany Ireland Italy +5
  • Study of Patritumab Deruxtecan for Patients with Brain Metastases from Advanced Breast or Lung Cancer and Leptomeningeal Disease from Solid Tumors

    Not recruiting

    2 1 1
    Investigated Drugs:
    Austria Spain
  • Study of Abemaciclib and Erlotinib for Patients with Stage IV Non-Small Cell Lung Cancer with KRAS Mutation After Platinum-Based Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of Avutometinib, Sotorasib, and Defactinib for Patients with KRAS G12C Mutant Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Belgium France The Netherlands Spain
  • Study on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Italy Poland Spain
  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Czechia Estonia France Germany Hungary Italy +6